Published 2023 | Version v1
Publication

Reply: novel antidiabetic drugs and the risk for hepatocellular carcinoma. What else to expect from these "wonderful" drug classes?

Additional details

Identifiers

URL
https://hdl.handle.net/11567/1110596
URN
urn:oai:iris.unige.it:11567/1110596

Origin repository

Origin repository
UNIGE